Recalled infusion pumps may cause serious injury

Jul 20, 2022 - 04:01 PM
syringe-recall

Smiths Medical recently recalled more than 118,000 Medfusion syringe infusion pumps whose software could malfunction, causing serious patient harm or death, the Food and Drug Administration announced. At least seven serious injuries and one death have been reported. For more on the affected models and recommended actions for clinicians, see the company’s April letter to customers.

Related News Articles

Headline
FDA announces firm distributing Chinese-made plastic syringes in the U.S. initiates recall 
The Food and Drug Administration May 23 announced that Medline Industries, a firm marketing and distributing Chinese-manufactured plastic syringes within the U…
Headline
FDA issues import alert, additional recommendations against using plastic syringes made in China 
The Food and Drug Administration yesterday announced an import alert for plastic syringes manufactured by two China-based manufacturers, in addition to…
Headline
FDA clarifies definition of 'remanufacturing' for medical devices needing maintenance
The Food and Drug Administration May 9 released final guidance clarifying the definition of “remanufacturing” for reusable medical devices needing…
Headline
FDA advises against using plastic syringes made in China
U.S. health care organizations should immediately transition away from using certain unauthorized plastic syringes made in China by Jiangsu Caina Medical Co.…
Headline
FDA approves combo test for flu, COVID-19; alerts providers to medical device risks 
The Food and Drug Administration recently granted emergency use authorization for the first over-the-counter home antigen test to detect both flu and COVID-19…
Headline
FDA adds vaporized hydrogen peroxide as an established medical device sterilization method 
In updated guidance for makers of medical devices labeled as sterile, the Food and Drug Administration Jan. 8 listed vaporized hydrogen peroxide as an…